Colorectal cancer can be classified into three types: sporadic, hereditary non-polyposis colorectal carcinoma (HNPCC), and familial adenomatous polyposis (FAP). Sporadic colon cancer is believed to be caused by a series of genetic mutations, including allelic loss of the APC gene, activation of the K-ras oncogene, and deletion of p53 and DCC tumor suppressor genes. HNPCC, which is an autosomal dominant condition, is the most common form of inherited colon cancer. It is caused by mutations in genes involved in DNA mismatch repair, leading to microsatellite instability. The most common genes affected are MSH2 and MLH1. Patients with HNPCC are also at a higher risk of other cancers, such as endometrial cancer. The Amsterdam criteria are sometimes used to aid diagnosis of HNPCC. FAP is a rare autosomal dominant condition that leads to the formation of hundreds of polyps by the age of 30-40 years. It is caused by a mutation in the APC gene. Patients with FAP are also at risk of duodenal tumors. A variant of FAP called Gardner’s syndrome can also feature osteomas of the skull and mandible, retinal pigmentation, thyroid carcinoma, and epidermoid cysts on the skin. Genetic testing can be done to diagnose HNPCC and FAP, and patients with FAP generally have a total colectomy with ileo-anal pouch formation in their twenties.

Sulphasalazine is the likely cause of megaloblastic anaemia in this patient, as her blood results indicate macrocytic anaemia and she has a history of ulcerative colitis for which she is taking the medication. Microcytic anaemia is commonly caused by poor iron intake, while sickle cell anaemia causes microcytic anaemia. Long-term use of sumatriptan is not associated with macrocytic anaemia. Although hypothyroidism can cause macrocytic anaemia, this option is incorrect as the patient’s thyroid function tests are normal.

Aminosalicylate Drugs for Inflammatory Bowel Disease

Aminosalicylate drugs are commonly used to treat inflammatory bowel disease (IBD). These drugs work by releasing 5-aminosalicyclic acid (5-ASA) in the colon, which acts as an anti-inflammatory agent. The exact mechanism of action is not fully understood, but it is believed that 5-ASA may inhibit prostaglandin synthesis.

Sulphasalazine is a combination of sulphapyridine and 5-ASA. However, many of the side effects associated with this drug are due to the sulphapyridine component, such as rashes, oligospermia, headache, Heinz body anaemia, megaloblastic anaemia, and lung fibrosis. Mesalazine is a delayed release form of 5-ASA that avoids the sulphapyridine side effects seen in patients taking sulphasalazine. However, it is still associated with side effects such as gastrointestinal upset, headache, agranulocytosis, pancreatitis, and interstitial nephritis.

Olsalazine is another aminosalicylate drug that consists of two molecules of 5-ASA linked by a diazo bond, which is broken down by colonic bacteria. It is important to note that aminosalicylates are associated with a variety of haematological adverse effects, including agranulocytosis. Therefore, a full blood count is a key investigation in an unwell patient taking these drugs. Pancreatitis is also more common in patients taking mesalazine compared to sulfasalazine.

The omental branches of the right and left gastro-epiploic arteries provide the blood supply to the omentum, while the colonic vessels do not play a role in this. The left gastro-epiploic artery originates from the splenic artery, and the right gastro-epiploic artery is the final branch of the gastroduodenal artery.

The Omentum: A Protective Structure in the Abdomen

The omentum is a structure in the abdomen that invests the stomach and is divided into two parts: the greater and lesser omentum. The greater omentum is attached to the lower lateral border of the stomach and contains the gastro-epiploic arteries. It varies in size and is less developed in children. However, it plays an important role in protecting against visceral perforation, such as in cases of appendicitis.

The lesser omentum is located between the omentum and transverse colon, providing a potential entry point into the lesser sac. Malignant processes can affect the omentum, with ovarian cancer being the most notable. Overall, the omentum is a crucial structure in the abdomen that serves as a protective barrier against potential injuries and diseases.

The development of intestinal diverticula is strongly linked to a low fibre diet, making it a major risk factor. To manage mild symptoms, patients are advised to modify their diet by gradually increasing fibre intake over several weeks and staying hydrated.

IV antibiotics and fluids are not necessary for diverticular disease, as it is not the same as diverticulitis.

Surgery is not recommended for uncomplicated diverticular disease.

While encouraging smoking cessation is important, dietary modification is the most suitable option for this patient.

Diverticulosis is a common condition where multiple outpouchings occur in the bowel wall, typically in the sigmoid colon. It is more accurate to use the term diverticulosis when referring to the presence of diverticula, while diverticular disease is reserved for symptomatic patients. Risk factors for this condition include a low-fibre diet and increasing age. Symptoms of diverticulosis can include altered bowel habits and colicky left-sided abdominal pain. A high-fibre diet is often recommended to alleviate these symptoms.

Diverticulitis is a complication of diverticulosis where one of the diverticula becomes infected. The typical presentation includes left iliac fossa pain and tenderness, anorexia, nausea, vomiting, diarrhea, and signs of infection such as pyrexia, raised WBC, and CRP. Mild attacks can be treated with oral antibiotics, while more severe episodes require hospitalization. Treatment involves nil by mouth, intravenous fluids, and intravenous antibiotics such as a cephalosporin and metronidazole. Complications of diverticulitis include abscess formation, peritonitis, obstruction, and perforation.

The classic triad for achalasia includes loss of peristalsis, increased lower sphincter tone, and inadequate relaxation of the lower sphincter, which is evident on manometry. Dysphagia for both solid and liquid is also a common symptom of achalasia.

Unlike achalasia, Barrett’s esophagus does not show any changes on manometry. However, it can be identified through the presence of intestinal metaplasia on endoscopy.

Diffuse esophageal spasm is a motility disorder that does not affect lower esophageal sphincter pressure and relaxation during swallowing. Instead, manometry reveals repetitive high amplitude contractions.

Hiatus hernia is typically associated with gastroesophageal reflux disease and does not show any abnormal findings on manometry.

Understanding Dysphagia and its Causes

Dysphagia, or difficulty in swallowing, can be caused by various conditions affecting the oesophagus, including cancer, oesophagitis, candidiasis, achalasia, pharyngeal pouch, systemic sclerosis, myasthenia gravis, and globus hystericus. These conditions have distinct features that can help in their diagnosis, such as weight loss and anorexia in oesophageal cancer, heartburn in oesophagitis, dysphagia of both liquids and solids in achalasia, and anxiety in globus hystericus. Dysphagia can also be classified as extrinsic, intrinsic, or neurological, depending on the underlying cause.

To diagnose dysphagia, patients usually undergo an upper GI endoscopy, a full blood count, and fluoroscopic swallowing studies. Additional tests, such as ambulatory oesophageal pH and manometry studies, may be needed for specific conditions. It’s important to note that new-onset dysphagia is a red flag symptom that requires urgent endoscopy, regardless of age or other symptoms. By understanding the causes and features of dysphagia, healthcare professionals can provide timely and appropriate management for their patients.

Metoclopramide use in children and young adults can lead to oculogyric crisis, which is a dystonic reaction that causes the eyes to involuntarily gaze upwards for an extended period. Opioids can cause respiratory depression, while cyclizine may result in restlessness and urinary retention. Amiodarone use may cause slate-grey skin discoloration. Additionally, metoclopramide can increase urinary frequency.

Understanding the Mechanism and Uses of Metoclopramide

Metoclopramide is a medication primarily used to manage nausea, but it also has other uses such as treating gastro-oesophageal reflux disease and gastroparesis secondary to diabetic neuropathy. It is often combined with analgesics for the treatment of migraines. However, it is important to note that metoclopramide has adverse effects such as extrapyramidal effects, acute dystonia, diarrhoea, hyperprolactinaemia, tardive dyskinesia, and parkinsonism. It should also be avoided in bowel obstruction but may be helpful in paralytic ileus.

The mechanism of action of metoclopramide is quite complicated. It is primarily a D2 receptor antagonist, but it also has mixed 5-HT3 receptor antagonist/5-HT4 receptor agonist activity. Its antiemetic action is due to its antagonist activity at D2 receptors in the chemoreceptor trigger zone, and at higher doses, the 5-HT3 receptor antagonist also has an effect. The gastroprokinetic activity is mediated by D2 receptor antagonist activity and 5-HT4 receptor agonist activity.

In summary, metoclopramide is a medication with multiple uses, but it also has adverse effects that should be considered. Its mechanism of action is complex, involving both D2 receptor antagonist and 5-HT3 receptor antagonist/5-HT4 receptor agonist activity. Understanding the uses and mechanism of action of metoclopramide is important for its safe and effective use.

The presentation of symptoms related to the conjugation of bilirubin varies depending on where the process is disrupted, such as pre-hepatic, hepatic, or post-hepatic. In this case, a mass in the pancreatic head has caused an obstruction of the common bile duct, which is post-hepatic. This obstruction results in less conjugated bilirubin reaching the intestinal tract and more being absorbed into the systemic circulation. As a result, there is a decrease in stercobilin production, leading to paler stools.

Pancreatic cancer is a type of cancer that is often diagnosed late due to its non-specific symptoms. The majority of pancreatic tumors are adenocarcinomas and are typically found in the head of the pancreas. Risk factors for pancreatic cancer include increasing age, smoking, diabetes, chronic pancreatitis, hereditary non-polyposis colorectal carcinoma, and mutations in the BRCA2 and KRAS genes.

Symptoms of pancreatic cancer can include painless jaundice, pale stools, dark urine, and pruritus. Courvoisier’s law states that a palpable gallbladder is unlikely to be due to gallstones in the presence of painless obstructive jaundice. However, patients often present with non-specific symptoms such as anorexia, weight loss, and epigastric pain. Loss of exocrine and endocrine function can also occur, leading to steatorrhea and diabetes mellitus. Atypical back pain and migratory thrombophlebitis (Trousseau sign) are also common.

Ultrasound has a sensitivity of around 60-90% for detecting pancreatic cancer, but high-resolution CT scanning is the preferred diagnostic tool. The ‘double duct’ sign, which is the simultaneous dilatation of the common bile and pancreatic ducts, may be seen on imaging.

Less than 20% of patients with pancreatic cancer are suitable for surgery at the time of diagnosis. A Whipple’s resection (pancreaticoduodenectomy) may be performed for resectable lesions in the head of the pancreas, but side-effects such as dumping syndrome and peptic ulcer disease can occur. Adjuvant chemotherapy is typically given following surgery, and ERCP with stenting may be used for palliation.

The absorption of Vitamin B12 is affected by post gastrectomy syndrome, while the absorption of other vitamins remains unaffected. This syndrome is characterized by the rapid emptying of food from the stomach into the duodenum, leading to symptoms such as abdominal pain, diarrhoea, and hypoglycaemia. Complications of this syndrome include malabsorption of Vitamin B12 and iron, as well as osteoporosis. Treatment involves following a diet that is high in protein and low in carbohydrates, and replacing any deficiencies in Vitamin B12, iron, and calcium.

Understanding Gastric Emptying and Its Controlling Factors

The stomach plays a crucial role in both mechanical and immunological functions. It retains solid and liquid materials, which undergo peristaltic activity against a closed pyloric sphincter, leading to fragmentation of food bolus material. Gastric acid helps neutralize any pathogens present. The time material spends in the stomach depends on its composition and volume, with amino acids and fat delaying gastric emptying.

Gastric emptying is controlled by neuronal stimulation mediated via the vagus and the parasympathetic nervous system, which favors an increase in gastric motility. Hormonal factors such as gastric inhibitory peptide, cholecystokinin, and enteroglucagon also play a role in delaying or increasing gastric emptying.

Diseases affecting gastric emptying can lead to bacterial overgrowth, retained food, and the formation of bezoars that may occlude the pylorus and worsen gastric emptying. Gastric surgery can also have profound effects on gastric emptying, with vagal disruption causing delayed emptying.

Diabetic gastroparesis is predominantly due to neuropathy affecting the vagus nerve, leading to poor stomach emptying and repeated vomiting. Malignancies such as distal gastric cancer and pancreatic cancer may also obstruct the pylorus and delay emptying. Congenital hypertrophic pyloric stenosis is a disease of infancy that presents with projectile non-bile stained vomiting and is treated with pyloromyotomy.

In summary, understanding gastric emptying and its controlling factors is crucial in diagnosing and treating various diseases that affect the stomach’s function.

The gastrointestinal system is accessed through the mouth, which serves as the entrance for food. The act of chewing and swallowing is initiated voluntarily. Once swallowed, the process becomes automatic. The oral cavity is divided into two main regions: the vestibule, which is located between the mucosa of the lips and cheeks and the teeth, and the oral cavity proper. These two regions are connected to each other at the back of the second molar tooth.

Understanding Oesophageal Candidiasis

Oesophageal candidiasis is a medical condition that is identified by the presence of white spots in the oropharynx, which can extend into the oesophagus. This condition is commonly associated with the use of broad-spectrum antibiotics, immunosuppression, and immunological disorders. Patients with oesophageal candidiasis may experience oropharyngeal symptoms, odynophagia, and dysphagia.

The treatment for oesophageal candidiasis involves addressing the underlying cause, which should be investigated by a medical professional. Additionally, oral antifungal agents are prescribed to manage the symptoms of the condition.

Co-danthramer is a genotoxic laxative that should only be prescribed to patients receiving palliative care due to its potential to cause cancer. Other laxatives should be considered first for patients with constipation. However, if constipation is not improved by other laxatives, co-danthramer may be prescribed to palliative patients. It is important to note that a high-fibre diet, adequate fluid intake, and exercise are recommended for all patients with constipation. Fruits and vegetables high in fibre and sorbitol, as well as fruit juices high in sorbitol, can also be helpful in preventing and treating constipation.

Understanding Laxatives

Laxatives are frequently prescribed medications in clinical practice, with constipation being a common issue among patients. While constipation may be a symptom of underlying pathology, many patients experience simple idiopathic constipation. The British National Formulary (BNF) categorizes laxatives into four groups: osmotic, stimulant, bulk-forming, and faecal softeners.

Osmotic laxatives, such as lactulose, macrogols, and rectal phosphates, work by drawing water into the bowel to soften stools and promote bowel movements. Stimulant laxatives, including senna, docusate, bisacodyl, and glycerol, stimulate the muscles in the bowel to contract and move stool along. Co-danthramer, a combination of a stimulant and a bulk-forming laxative, should only be prescribed to palliative patients due to its potential carcinogenic effects.

Bulk-forming laxatives, such as ispaghula husk and methylcellulose, work by increasing the bulk of stool and promoting regular bowel movements. Faecal softeners, such as arachis oil enemas, are not commonly prescribed but can be used to soften stool and ease bowel movements.

In summary, understanding the different types of laxatives and their mechanisms of action can help healthcare professionals prescribe the most appropriate treatment for patients experiencing constipation.

The patient has Barrett’s oesophagus, which is a metaplastic condition where the normal oesophageal epithelium is replaced by columnar cells. This increases the risk of adenocarcinoma.

Barrett’s oesophagus is a condition where the lower oesophageal mucosa is replaced by columnar epithelium, which increases the risk of oesophageal adenocarcinoma by 50-100 fold. It is usually identified during an endoscopy for upper gastrointestinal symptoms such as dyspepsia, as there are no screening programs for it. The length of the affected segment determines the chances of identifying metaplasia, with short (<3 cm) and long (>3 cm) subtypes. The prevalence of Barrett’s oesophagus is estimated to be around 1 in 20, and it is identified in up to 12% of those undergoing endoscopy for reflux.

The columnar epithelium in Barrett’s oesophagus may resemble that of the cardiac region of the stomach or that of the small intestine, with goblet cells and brush border. The single strongest risk factor for Barrett’s oesophagus is gastro-oesophageal reflux disease (GORD), followed by male gender, smoking, and central obesity. Alcohol is not an independent risk factor for Barrett’s, but it is associated with both GORD and oesophageal cancer. Patients with Barrett’s oesophagus often have coexistent GORD symptoms.

The management of Barrett’s oesophagus involves high-dose proton pump inhibitor, although the evidence base for its effectiveness in reducing the progression to dysplasia or inducing regression of the lesion is limited. Endoscopic surveillance with biopsies is recommended every 3-5 years for patients with metaplasia but not dysplasia. If dysplasia of any grade is identified, endoscopic intervention is offered, such as radiofrequency ablation, which is the preferred first-line treatment, particularly for low-grade dysplasia, or endoscopic mucosal resection.

Duodenal ulceration cases can be caused by Helicobacter pylori infection, which can be diagnosed through serology, microbiology, histology, or CLO testing. Detecting the infection through endoscopy may not show any typical features, so the recommended approach is to take an antral biopsy for CLO testing during the endoscopy procedure.

Helicobacter pylori: A Bacteria Associated with Gastrointestinal Problems

Helicobacter pylori is a type of Gram-negative bacteria that is commonly associated with various gastrointestinal problems, particularly peptic ulcer disease. This bacterium has two primary mechanisms that allow it to survive in the acidic environment of the stomach. Firstly, it uses its flagella to move away from low pH areas and burrow into the mucous lining to reach the epithelial cells underneath. Secondly, it secretes urease, which converts urea to NH3, leading to an alkalinization of the acidic environment and increased bacterial survival.

The pathogenesis mechanism of Helicobacter pylori involves the release of bacterial cytotoxins, such as the CagA toxin, which can disrupt the gastric mucosa. This bacterium is associated with several gastrointestinal problems, including peptic ulcer disease, gastric cancer, B cell lymphoma of MALT tissue, and atrophic gastritis. However, its role in gastro-oesophageal reflux disease (GORD) is unclear, and there is currently no role for the eradication of Helicobacter pylori in GORD.

The management of Helicobacter pylori infection involves a 7-day course of treatment with a proton pump inhibitor, amoxicillin, and either clarithromycin or metronidazole. For patients who are allergic to penicillin, a proton pump inhibitor, metronidazole, and clarithromycin are used instead.

Colorectal cancer can be classified into three types: sporadic, hereditary non-polyposis colorectal carcinoma (HNPCC), and familial adenomatous polyposis (FAP). Sporadic colon cancer is believed to be caused by a series of genetic mutations, including allelic loss of the APC gene, activation of the K-ras oncogene, and deletion of p53 and DCC tumor suppressor genes. HNPCC, which is an autosomal dominant condition, is the most common form of inherited colon cancer. It is caused by mutations in genes involved in DNA mismatch repair, leading to microsatellite instability. The most common genes affected are MSH2 and MLH1. Patients with HNPCC are also at a higher risk of other cancers, such as endometrial cancer. The Amsterdam criteria are sometimes used to aid diagnosis of HNPCC. FAP is a rare autosomal dominant condition that leads to the formation of hundreds of polyps by the age of 30-40 years. It is caused by a mutation in the APC gene. Patients with FAP are also at risk of duodenal tumors. A variant of FAP called Gardner’s syndrome can also feature osteomas of the skull and mandible, retinal pigmentation, thyroid carcinoma, and epidermoid cysts on the skin. Genetic testing can be done to diagnose HNPCC and FAP, and patients with FAP generally have a total colectomy with ileo-anal pouch formation in their twenties.

Rectal cancer is characterized by symptoms such as passing fresh blood, which distinguishes it from duodenal cancer that presents with upper gastrointestinal bleeding. Inflammatory bowel disease typically includes abdominal pain, fever, and passing bloody stools, and may have more severe presentations, but microcytic anemia is not a common feature. Irritable bowel syndrome does not involve passing bloody stools and is associated with vague symptoms like bloating, backache, and urinary problems. Gastroenteritis is unlikely as it is accompanied by vomiting, diarrhea, and fever, which the patient has not reported.

Colorectal cancer is a prevalent type of cancer in the UK, ranking third in terms of frequency and second in terms of cancer-related deaths. Every year, approximately 150,000 new cases are diagnosed, and 50,000 people die from the disease. The cancer can occur in different parts of the colon, with the rectum being the most common location, accounting for 40% of cases. The sigmoid colon follows closely, with 30% of cases, while the descending colon has only 5%. The transverse colon has 10% of cases, and the ascending colon and caecum have 15%.

Ischemic colitis is a condition where blood flow to a part of the large intestine is temporarily reduced, often due to a blockage or hypo-perfusion. While any part of the colon can be affected, it most commonly affects the left side. The hepatic flexure, located on the right side of the colon, is less likely to be involved as it has a good blood supply from the superior mesenteric artery (SMA). The ileocecal junction is also less likely to be affected as it has a good blood supply from the ileocolic artery, a branch of the SMA. The splenic flexure, located between the left colon and the transverse colon, is the most likely area to be affected by ischaemic colitis as it is a watershed area supplied by the inferior mesenteric artery. The sigmoid colon, supplied by the sigmoidal branches of the inferior mesenteric artery, is less likely to be affected. The recto-sigmoid junction is also a watershed area and vulnerable to ischaemic colitis, but it is less common than ischaemia at the splenic flexure.

Ischaemia to the lower gastrointestinal tract can result in acute mesenteric ischaemia, chronic mesenteric ischaemia, and ischaemic colitis. Common predisposing factors include increasing age, atrial fibrillation, other causes of emboli, cardiovascular disease risk factors, and cocaine use. Common features include abdominal pain, rectal bleeding, diarrhea, fever, and elevated white blood cell count with lactic acidosis. CT is the investigation of choice. Acute mesenteric ischaemia is typically caused by an embolism and requires urgent surgery. Chronic mesenteric ischaemia presents with intermittent abdominal pain. Ischaemic colitis is an acute but transient compromise in blood flow to the large bowel and may require surgery in a minority of cases.

Polyposis syndromes are a group of genetic disorders that cause the development of multiple polyps in the colon and other parts of the gastrointestinal tract. These polyps can increase the risk of developing cancer, and therefore, early detection and management are crucial. There are several types of polyposis syndromes, each with its own genetic defect, features, and associated disorders.

Familial adenomatous polyposis (FAP) is caused by a mutation in the APC gene and is characterized by the development of over 100 colonic adenomas, with a 100% risk of cancer. Screening and management involve regular colonoscopies and resectional surgery if polyps are found. FAP is also associated with gastric and duodenal polyps and abdominal desmoid tumors.

MYH-associated polyposis is caused by a biallelic mutation of the MYH gene and is associated with multiple colonic polyps and an increased risk of right-sided cancers. Attenuated phenotype can be managed with regular colonoscopies, while resection and ileoanal pouch reconstruction are recommended for those with multiple polyps.

Peutz-Jeghers syndrome is caused by a mutation in the STK11 gene and is characterized by multiple benign intestinal hamartomas, episodic obstruction, and an increased risk of GI cancers. Screening involves annual examinations and pan-intestinal endoscopy every 2-3 years.

Cowden disease is caused by a mutation in the PTEN gene and is characterized by macrocephaly, multiple intestinal hamartomas, and an increased risk of cancer at any site. Targeted individualized screening is recommended, with extra surveillance for breast, thyroid, and uterine cancers.

HNPCC (Lynch syndrome) is caused by germline mutations of DNA mismatch repair genes and is associated with an increased risk of colorectal, endometrial, and gastric cancers. Colonoscopies every 1-2 years from age 25 and consideration of prophylactic surgery are recommended, along with extra colonic surveillance.

Pseudomembranous colitis is caused by the gram-positive bacillus Clostridium difficile, which can overgrow in the intestine following broad-spectrum antibiotic use. A patient recovering from a total hip replacement who develops signs of infection and is treated with clindamycin may develop severe abdominal pain and diarrhea, indicating a diagnosis of pseudomembranous colitis. Treatment options include metronidazole or oral vancomycin for more severe cases. Staphylococcus bacteria are gram-positive, catalase-positive cocci that can be differentiated based on coagulase positivity and novobiocin sensitivity. Listeria, Bacillus, and Corynebacterium are gram-positive aerobic bacilli, while Campylobacter jejuni, Vibrio cholerae, and Helicobacter pylori are gram-negative, oxidase-positive comma-shaped rods with specific growth characteristics.

Clostridium difficile is a type of bacteria that is commonly found in hospitals. It produces a toxin that can damage the intestines and cause a condition called pseudomembranous colitis. This bacteria usually develops when the normal gut flora is disrupted by broad-spectrum antibiotics, with second and third generation cephalosporins being the leading cause. Other risk factors include the use of proton pump inhibitors. Symptoms of C. difficile infection include diarrhea, abdominal pain, and a raised white blood cell count. The severity of the infection can be determined using the Public Health England severity scale.

To diagnose C. difficile infection, a stool sample is tested for the presence of the C. difficile toxin. Treatment involves reviewing current antibiotic therapy and stopping antibiotics if possible. For a first episode of infection, oral vancomycin is the first-line therapy for 10 days, followed by oral fidaxomicin as second-line therapy and oral vancomycin with or without IV metronidazole as third-line therapy. Recurrent infections may require different treatment options, such as oral fidaxomicin within 12 weeks of symptom resolution or oral vancomycin or fidaxomicin after 12 weeks of symptom resolution. In life-threatening cases, oral vancomycin and IV metronidazole may be used, and surgery may be considered with specialist advice. Other therapies, such as bezlotoxumab and fecal microbiota transplant, may also be considered for preventing recurrences in certain cases.

The pudendal nerve branches provide innervation to the external urethral sphincter, indicating that the root values are S2, S3, S4.

Urethral Anatomy: Differences Between Male and Female

The anatomy of the urethra differs between males and females. In females, the urethra is shorter and more angled than in males. It is located outside of the peritoneum and is surrounded by the endopelvic fascia. The neck of the bladder is subject to intra-abdominal pressure, and any weakness in this area can lead to stress urinary incontinence. The female urethra is surrounded by the external urethral sphincter, which is innervated by the pudendal nerve. It is located in front of the vaginal opening.

In males, the urethra is much longer and is divided into four parts. The pre-prostatic urethra is very short and lies between the bladder and prostate gland. The prostatic urethra is wider than the membranous urethra and contains several openings for the transmission of semen. The membranous urethra is the narrowest part of the urethra and is surrounded by the external sphincter. The penile urethra travels through the corpus spongiosum on the underside of the penis and is the longest segment of the urethra. The bulbo-urethral glands open into the spongiose section of the urethra.

The urothelium, which lines the inside of the urethra, is transitional near the bladder and becomes squamous further down the urethra. Understanding the differences in urethral anatomy between males and females is important for diagnosing and treating urological conditions.

An upper gastrointestinal (GI) bleed can lead to the formation of melaena, which is characterized by the passage of dark and tarry stool through the digestive tract. Peptic ulcer is a frequent cause of upper GI bleed, particularly in patients who have identifiable risk factors such as the use of NSAIDs, as seen in this patient.

The blood tests reveal an elevated urea level without an increase in creatinine, which is a typical presentation in an upper GI bleed. Additionally, the presence of anemia is also suggestive of a bleed.

Acute upper gastrointestinal bleeding is a common and significant medical issue that can be caused by various conditions, with oesophageal varices and peptic ulcer disease being the most common. The main symptoms include haematemesis (vomiting of blood), melena (passage of altered blood per rectum), and a raised urea level due to the protein meal of the blood. The diagnosis can be determined by identifying the specific features associated with a particular condition, such as stigmata of chronic liver disease for oesophageal varices or abdominal pain for peptic ulcer disease.

The differential diagnosis for acute upper gastrointestinal bleeding includes oesophageal, gastric, and duodenal causes. Oesophageal varices may present with a large volume of fresh blood, while gastric ulcers may cause low volume bleeds that present as iron deficiency anaemia. Duodenal ulcers are usually posteriorly sited and may erode the gastroduodenal artery. Aorto-enteric fistula is a rare but important cause of major haemorrhage associated with high mortality in patients with previous abdominal aortic aneurysm surgery.

The management of acute upper gastrointestinal bleeding involves risk assessment using the Glasgow-Blatchford score, which helps clinicians decide whether patients can be managed as outpatients or not. Resuscitation involves ABC, wide-bore intravenous access, and platelet transfusion if actively bleeding platelet count is less than 50 x 10*9/litre. Endoscopy should be offered immediately after resuscitation in patients with a severe bleed, and all patients should have endoscopy within 24 hours. Treatment options include repeat endoscopy, interventional radiology, and surgery for non-variceal bleeding, while terlipressin and prophylactic antibiotics should be given to patients with variceal bleeding. Band ligation should be used for oesophageal varices, and injections of N-butyl-2-cyanoacrylate for patients with gastric varices. Transjugular intrahepatic portosystemic shunts (TIPS) should be offered if bleeding from varices is not controlled with the above measures.

CCK is a hormone produced by I cells in the upper small intestine that enhances the digestion of fats and proteins. When partially digested proteins and fats are detected, CCK is synthesized and released, resulting in various processes such as the secretion of digestive enzymes from the pancreas, contraction of the gallbladder, relaxation of the sphincter of Oddi, decreased gastric emptying, and a trophic effect on pancreatic acinar cells. These processes lead to the breakdown of fats and proteins and suppression of hunger.

B cells, on the other hand, are part of the immune system and produce antibodies as part of the B cell receptors. They are produced in the bone marrow and migrate to the spleen and lymphatic system, but they do not play a role in satiety.

Somatostatin is a hormone released from D cells in the pancreas and stomach that regulates peptide hormone release and gastric emptying. It is stimulated by the presence of fat, bile salt, and glucose in the intestines.

Gastrin is a hormone that increases acid release from parietal cells in the stomach and aids in gastric motility. It is released from G cells in the antrum of the stomach in response to distension of the stomach, stimulation of the vagus nerves, and the presence of peptides/amino acids in the lumen.

Secretin is a hormone that regulates enzyme secretion from the stomach, pancreas, and liver. It is released from the S cells in the duodenum in response to the presence of acid in the lumen.

Overview of Gastrointestinal Hormones

Gastrointestinal hormones play a crucial role in the digestion and absorption of food. These hormones are secreted by various cells in the stomach and small intestine in response to different stimuli such as the presence of food, pH changes, and neural signals.

One of the major hormones involved in food digestion is gastrin, which is secreted by G cells in the antrum of the stomach. Gastrin increases acid secretion by gastric parietal cells, stimulates the secretion of pepsinogen and intrinsic factor, and increases gastric motility. Another hormone, cholecystokinin (CCK), is secreted by I cells in the upper small intestine in response to partially digested proteins and triglycerides. CCK increases the secretion of enzyme-rich fluid from the pancreas, contraction of the gallbladder, and relaxation of the sphincter of Oddi. It also decreases gastric emptying and induces satiety.

Secretin is another hormone secreted by S cells in the upper small intestine in response to acidic chyme and fatty acids. Secretin increases the secretion of bicarbonate-rich fluid from the pancreas and hepatic duct cells, decreases gastric acid secretion, and has a trophic effect on pancreatic acinar cells. Vasoactive intestinal peptide (VIP) is a neural hormone that stimulates secretion by the pancreas and intestines and inhibits acid secretion.

Finally, somatostatin is secreted by D cells in the pancreas and stomach in response to fat, bile salts, and glucose in the intestinal lumen. Somatostatin decreases acid and pepsin secretion, decreases gastrin secretion, decreases pancreatic enzyme secretion, and decreases insulin and glucagon secretion. It also inhibits the trophic effects of gastrin and stimulates gastric mucous production.

In summary, gastrointestinal hormones play a crucial role in regulating the digestive process and maintaining homeostasis in the gastrointestinal tract.

The probable condition affecting the patient is hereditary haemochromatosis, which is inherited in an autosomal recessive manner. The presence of iron overload and abnormal liver function tests are indicative of this diagnosis. Additionally, the patient’s elevated blood glucose levels and skin pigmentation changes may suggest the presence of bronze diabetes.

Understanding Haemochromatosis: Symptoms and Complications

Haemochromatosis is a genetic disorder that affects iron absorption and metabolism, leading to iron accumulation in the body. It is caused by mutations in the HFE gene on both copies of chromosome 6. This disorder is prevalent in people of European descent, with 1 in 10 carrying a mutation in the genes affecting iron metabolism. Early symptoms of haemochromatosis are often non-specific, such as lethargy and arthralgia, and may go unnoticed. However, as the disease progresses, patients may experience fatigue, erectile dysfunction, and skin pigmentation.

Other complications of haemochromatosis include diabetes mellitus, liver disease, cardiac failure, hypogonadism, and arthritis. While some symptoms are reversible with treatment, such as cardiomyopathy, skin pigmentation, diabetes mellitus, hypogonadotrophic hypogonadism, and arthropathy, liver cirrhosis is irreversible.

Rovsing’s sign is a sign that may indicate the presence of appendicitis. It is considered positive when pressure applied to the left lower quadrant of the abdomen causes pain in the right lower quadrant.

Murphy’s sign is a sign that may indicate inflammation of the gallbladder. It is considered positive when pressure applied to the right upper quadrant of the abdomen, just below the rib cage, causes pain when the patient inhales.

Cullen’s sign is a sign that may indicate ectopic pregnancy or acute pancreatitis. It is characterized by bruising around the belly button.

Tinel’s sign is a sign that may indicate carpal tunnel syndrome. It is considered positive when tapping the median nerve over the flexor retinaculum causes tingling or numbness in the distribution of the median nerve.

Battles sign is a sign that may indicate a basal skull fracture of the posterior cranial fossa. It is characterized by bruising behind the ear.

Acute appendicitis is a common condition that requires surgery and can occur at any age, but is most prevalent in young people aged 10-20 years. The pathogenesis of acute appendicitis involves lymphoid hyperplasia or a faecolith, which leads to obstruction of the appendiceal lumen. This obstruction causes gut organisms to invade the appendix wall, resulting in oedema, ischaemia, and possibly perforation.

The most common symptom of acute appendicitis is abdominal pain, which is typically peri-umbilical and radiates to the right iliac fossa due to localised peritoneal inflammation. Other symptoms include mild pyrexia, anorexia, and nausea. Examination may reveal generalised or localised peritonism, rebound and percussion tenderness, guarding and rigidity, and classical signs such as Rovsing’s sign and psoas sign.

Diagnosis of acute appendicitis is typically based on raised inflammatory markers and compatible history and examination findings. Imaging may be used in certain cases, such as ultrasound in females where pelvic organ pathology is suspected. Management of acute appendicitis involves appendicectomy, which can be performed via an open or laparoscopic approach. Patients with perforated appendicitis require copious abdominal lavage, while those without peritonitis who have an appendix mass should receive broad-spectrum antibiotics and consideration given to performing an interval appendicectomy. Intravenous antibiotics alone have been trialled as a treatment for appendicitis, but evidence suggests that this is associated with a longer hospital stay and up to 20% of patients go on to have an appendicectomy within 12 months.

Understanding Gastric Secretions for Surgical Procedures

A basic understanding of gastric secretions is crucial for surgeons, especially when dealing with patients who have undergone acid-lowering procedures or are prescribed anti-secretory drugs. Gastric acid, produced by the parietal cells in the stomach, has a pH of around 2 and is maintained by the H+/K+ ATPase pump. Sodium and chloride ions are actively secreted from the parietal cell into the canaliculus, creating a negative potential across the membrane. Carbonic anhydrase forms carbonic acid, which dissociates, and the hydrogen ions formed by dissociation leave the cell via the H+/K+ antiporter pump. This leaves hydrogen and chloride ions in the canaliculus, which mix and are secreted into the lumen of the oxyntic gland.

There are three phases of gastric secretion: the cephalic phase, gastric phase, and intestinal phase. The cephalic phase is stimulated by the smell or taste of food and causes 30% of acid production. The gastric phase, which is caused by stomach distension, low H+, or peptides, causes 60% of acid production. The intestinal phase, which is caused by high acidity, distension, or hypertonic solutions in the duodenum, inhibits gastric acid secretion via enterogastrones and neural reflexes.

The regulation of gastric acid production involves various factors that increase or decrease production. Factors that increase production include vagal nerve stimulation, gastrin release, and histamine release. Factors that decrease production include somatostatin, cholecystokinin, and secretin. Understanding these factors and their associated pharmacology is essential for surgeons.

In summary, a working knowledge of gastric secretions is crucial for surgical procedures, especially when dealing with patients who have undergone acid-lowering procedures or are prescribed anti-secretory drugs. Understanding the phases of gastric secretion and the regulation of gastric acid production is essential for successful surgical outcomes.

Using CEA as a screening tool for colonic cancer is not justifiable. While it is true that CEA levels are elevated in colonic cancer, this is also the case in non-malignant conditions such as cirrhosis and colitis. Additionally, the highest levels of CEA are typically seen in cases of metastatic disease. Therefore, CEA should not be used to monitor colitis patients for the development of colonic cancer. This information is supported by a study published in the BMJ in 2009.

Diagnosis and Staging of Colorectal Cancer

Diagnosis of colorectal cancer is typically done through a colonoscopy, which is considered the gold standard as long as it is complete and provides good mucosal visualization. Other options for diagnosis include double-contrast barium enema and CT colonography. Once a malignant diagnosis is made, patients will undergo staging using chest, abdomen, and pelvic CT scans. Patients with rectal cancer will also undergo evaluation of the mesorectum with pelvic MRI scanning. For examination purposes, the Dukes and TNM systems are preferred.

Tumour Markers in Colorectal Cancer

Carcinoembryonic antigen (CEA) is the main tumour marker in colorectal cancer. While not all tumours secrete CEA, it is still used as a marker for disease burden and is once again being used routinely in follow-up. However, it is important to note that CEA levels may also be raised in conditions such as IBD.

The patient’s symptoms and CT findings suggest that they may have suffered iatrogenic damage to their ureters, which are retroperitoneal organs. This can lead to fluid accumulation in the retroperitoneal space, causing haematuria, abdominal/flank pain, and incontinence. While calculi and lithotripsy can damage the ureter mucosal lining, they are unlikely to have caused fluid accumulation in the intra-abdominal cavity, especially since the lithotripsy was performed a year ago. Pelvic inflammatory disease and urinary tract infections can cause similar symptoms, but their CT findings would be different.

The retroperitoneal structures are those that are located behind the peritoneum, which is the membrane that lines the abdominal cavity. These structures include the duodenum (2nd, 3rd, and 4th parts), ascending and descending colon, kidneys, ureters, aorta, and inferior vena cava. They are situated in the back of the abdominal cavity, close to the spine. In contrast, intraperitoneal structures are those that are located within the peritoneal cavity, such as the stomach, duodenum (1st part), jejunum, ileum, transverse colon, and sigmoid colon. It is important to note that the retroperitoneal structures are not well demonstrated in the diagram as the posterior aspect has been removed, but they are still significant in terms of their location and function.

Adenocarcinomas are frequently occurring and usually develop due to the sequence of adenoma leading to carcinoma.

Colorectal cancer is a prevalent type of cancer in the UK, ranking third in terms of frequency and second in terms of cancer-related deaths. Every year, approximately 150,000 new cases are diagnosed, and 50,000 people die from the disease. The cancer can occur in different parts of the colon, with the rectum being the most common location, accounting for 40% of cases. The sigmoid colon follows closely, with 30% of cases, while the descending colon has only 5%. The transverse colon has 10% of cases, and the ascending colon and caecum have 15%.

Individuals with Gilbert’s syndrome exhibit a decrease in the amount of UDP glucuronosyltransferase, an enzyme responsible for conjugating bilirubin in the liver. This deficiency leads to an accumulation of unconjugated bilirubin, which cannot be eliminated through urine, resulting in jaundice. Although symptoms may arise during periods of stress, the condition is generally not clinically significant.

HMG-CoA reductase is an enzyme involved in cholesterol synthesis, while lipoprotein lipase plays a central role in lipid metabolism and is associated with various conditions such as hypertriglyceridemia. G6PD deficiency, on the other hand, affects the pentose phosphate pathway by reducing the production of NADPH.

Gilbert’s syndrome is a genetic disorder that affects the way bilirubin is processed in the body. It is caused by a deficiency of UDP glucuronosyltransferase, which leads to unconjugated hyperbilirubinemia. This means that bilirubin is not properly broken down and eliminated from the body, resulting in jaundice. However, jaundice may only be visible during certain conditions such as fasting, exercise, or illness. The prevalence of Gilbert’s syndrome is around 1-2% in the general population.

To diagnose Gilbert’s syndrome, doctors may look for a rise in bilirubin levels after prolonged fasting or the administration of IV nicotinic acid. However, treatment is not necessary for this condition. While the exact mode of inheritance is still debated, it is known to be an autosomal recessive disorder.

Differential Diagnosis for Rectal Bleeding

Rectal bleeding can be a concerning symptom for patients and healthcare providers alike. While neoplasia may be a possible cause, diverticular disease is more common. To confirm the presence of diverticula, a barium enema should be performed, and a sigmoidoscopy should be done to rule out a tumor. Cystitis is rare in men and would present with symptoms such as urinary frequency, urgency, nocturia, and dysuria. Inflammatory bowel disease can affect any part of the gastrointestinal tract and often presents with weight loss, fever, malaise, and potentially arthralgia. However, the lack of systemic symptoms suggests an alternative diagnosis. Ulcerative colitis often causes rectal bleeding, while Crohn’s disease can cause rectal bleeding and inflammation from the mouth to anus. It is more commonly diagnosed in patients before the age of 30. It is important to consider these differential diagnoses when evaluating a patient with rectal bleeding to ensure appropriate management and treatment.

Further Reading:
Janes SE, Meagher A, Frizelle FA. Management of diverticulitis. BMJ. 2006;332:271-5.

The inferior thyroid artery supplies the cervical oesophagus, while direct branches from the thoracic aorta supply the thoracic oesophagus (which has been removed in this case).

Anatomy of the Oesophagus

The oesophagus is a muscular tube that is approximately 25 cm long and starts at the C6 vertebrae, pierces the diaphragm at T10, and ends at T11. It is lined with non-keratinized stratified squamous epithelium and has constrictions at various distances from the incisors, including the cricoid cartilage at 15cm, the arch of the aorta at 22.5cm, the left principal bronchus at 27cm, and the diaphragmatic hiatus at 40cm.

The oesophagus is surrounded by various structures, including the trachea to T4, the recurrent laryngeal nerve, the left bronchus and left atrium, and the diaphragm anteriorly. Posteriorly, it is related to the thoracic duct to the left at T5, the hemiazygos to the left at T8, the descending aorta, and the first two intercostal branches of the aorta. The arterial, venous, and lymphatic drainage of the oesophagus varies depending on the location, with the upper third being supplied by the inferior thyroid artery and drained by the deep cervical lymphatics, the mid-third being supplied by aortic branches and drained by azygos branches and mediastinal lymphatics, and the lower third being supplied by the left gastric artery and drained by posterior mediastinal and coeliac veins and gastric lymphatics.

The nerve supply of the oesophagus also varies, with the upper half being supplied by the recurrent laryngeal nerve and the lower half being supplied by the oesophageal plexus of the vagus nerve. The muscularis externa of the oesophagus is composed of both smooth and striated muscle, with the composition varying depending on the location.

Diphenoxylate slows down peristalsis in the GI tract by acting on μ-opioid receptors.

Increased gut motility can be achieved through the positive cholinergic effect of muscarinic receptor activation.

All other options are inaccurate.

Antidiarrhoeal Agents: Opioid Agonists

Antidiarrhoeal agents are medications used to treat diarrhoea. Opioid agonists are a type of antidiarrhoeal agent that work by slowing down the movement of the intestines, which reduces the frequency and urgency of bowel movements. Two common opioid agonists used for this purpose are loperamide and diphenoxylate.

Loperamide is available over-the-counter and is often used to treat acute diarrhoea. It works by binding to opioid receptors in the intestines, which reduces the contractions of the muscles in the intestinal wall. This slows down the movement of food and waste through the intestines, allowing more time for water to be absorbed and resulting in firmer stools.

Diphenoxylate is a prescription medication that is often used to treat chronic diarrhoea. It works in a similar way to loperamide, but is often combined with atropine to discourage abuse and overdose.

Overall, opioid agonists are effective at treating diarrhoea, but should be used with caution and under the guidance of a healthcare professional. They can cause side effects such as constipation, dizziness, and nausea, and may interact with other medications.